Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in childrenTimothy P Cripe, Chun-Yu Chen, Nicholas L Denton, et al.
Journal of Virology|March 2, 2012
Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12James M Markert, James J Cody, Jacqueline N Parker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2022
Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB StudyKatherine E Miller, Kevin A Cassady, Justin C Roth, et al.
Journal of Neuro-Oncology|November 22, 2018
Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesisZhong Liu, Pulin Che, Juan J Mercado, et al.
Pharmacology & Therapeutics|April 29, 2022
Clinical advances in oncolytic virotherapy for pediatric brain tumorsGelare Ghajar-Rahimi, Kyung-Don Kang, Stacie K Totsch, et al.
Journal of Neuro-Oncology|February 26, 2015
Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomasAsim K Bag, Hyunki Kim, Yi Gao, et al.
Cancers|February 15, 2022
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic VirotherapyColin H Quinn, Andee M Beierle, Sara Claire Hutchins, et al.
Frontiers in Surgery|October 2, 2020
The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade GliomasM R Chambers, R Timothy Bentley, David K Crossman, et al.
Theranostics|January 22, 2024
[<sup>89</sup>Zr]-CD8 ImmunoPET imaging of glioblastoma multiforme response to combination oncolytic viral and checkpoint inhibitor immunotherapy reveals CD8 infiltration differential changes in preclinical modelsCarlos A Gallegos, Yun Lu, Jennifer C Clements, et al.
Human Gene Therapy. Clinical Development|March 22, 2014
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primatesJustin C Roth, Kevin A Cassady, James J Cody, et al.
Pageof 14